Search results
Results From The WOW.Com Content Network
Purdue argued—and the bankruptcy court and 2nd Circuit agreed—that three key sections of the bankruptcy code, taken together, authorize a bankruptcy court to grant such releases: sections 105 ...
The Supreme Court in August 2023 paused bankruptcy proceedings concerning Purdue and its affiliates when they agreed to take up the administration's appeal of the 2nd Circuit's ruling.
Laws applied. Title 11 of the United States Code. Harrington v. Purdue Pharma L.P., (Docket No. 23-124), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. [1] This case is about the settlement by Purdue Pharmaceutical for Opioid victims who overdosed with the OxyContin drug produced by their company.
Bottles of Purdue Pharma L.P. OxyContin medication sit on a pharmacy shelf in Provo, Utah on Aug. 31, 2016. ... the New York-based 2nd U.S. Circuit Court of Appeals approved the plan over the ...
The New York-based 2nd Circuit U.S. Court of Appeals last year approved the plan over the objection of William Harrington, the U.S. government trustee monitoring the bankruptcy.
The United States Court of Appeals for the Second Circuit (in case citations, 2d Cir.) is one of the thirteen United States Courts of Appeals. Its territory covers the states of Connecticut, New York, and Vermont, and it has appellate jurisdiction over the U.S. district courts in the following federal judicial districts :
Purdue Pharma L.P. Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants. [1] [2]
The 2nd U.S. Circuit court of appeals approved Purdue's bankruptcy plan in May, ruling that the company can shield its owners from opioid lawsuits in exchange for a $6 billion contribution to the ...